CN2553828Y - AIDS treatment apparatus - Google Patents
AIDS treatment apparatus Download PDFInfo
- Publication number
- CN2553828Y CN2553828Y CN 02222777 CN02222777U CN2553828Y CN 2553828 Y CN2553828 Y CN 2553828Y CN 02222777 CN02222777 CN 02222777 CN 02222777 U CN02222777 U CN 02222777U CN 2553828 Y CN2553828 Y CN 2553828Y
- Authority
- CN
- China
- Prior art keywords
- magnetic
- sound source
- control
- tunnel type
- heavy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The utility model provides an AIDS treatment apparatus adopting the conception of physical immunity(field immunity), namely, the design of magnet-gravity acoustic field. Consisting of a tunnel type body, a magnet-gravity acoustic source, a mobile treatment bed and a control platform, the utility model overcomes the defects of the prior medical apparatus for AIDS and provides a novel medical apparatus with simple structure and low cost. Besides, the utility model can effectively improve the function of the human body immunity system, activate the immunocyte harmed by the AIDS virus, rebuilt the comprehensive immunologic function of the patient, improve the response ability to specific immunity of ADIS virus and opportunistic infection of the AIDS virus, effectively restrain and kill the ADIS virus without distinctly adverse reaction.
Description
This utility model relates to Medical Instruments.Particularly utilize the Medical Instruments of the heavy sound field treatment of magnetic acquired immune deficiency syndrome (AIDS).
Over 20 years, the people of global aids infection virus (HIV) surpasses 5,800 ten thousand, to dead 2,200 ten thousand people of calendar year 2001 accumulative total.HIV sufferers 250,000 examples found of China estimate that according to the expert actual number of the infected surpasses 600,000, and to be higher than 30% speed increment every year.
Acquired immune deficiency syndrome (AIDS) does not have effective treatment means so far.The HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) speed of mutation is too fast, and the Drug resistance of generation makes vaccine and the drug failure that prevents AIDS.Though multiple treatment AIDS-treating medicine is used (HAART) together, can reduce the acquired immune deficiency syndrome (AIDS) mortality rate, prolong patient's life, expense is surprising, is difficult to promote in developing country.Be exactly above-mentioned therapy, also can't thoroughly kill HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) that is in resting state just can be brought back to life as occasion serves, quickens to duplicate diffusion.At " external techwatch " the 9th phase of calendar year 2001 3-12 page or leaf acquired immune deficiency syndrome (AIDS) special topic: " medicine of existing AIDS virus resisting can stop duplicating of virus to a certain extent; but can not treatment of AIDS viral infection person and acquired immune deficiency syndrome (AIDS), and have than serious adverse.Some nucleoside reverse transcriptase inhibitor can cause cell and leukocyte disappearance, and is all the more so when particularly acquired immune deficiency syndrome (AIDS) is taken late period.Other nucleoside reverse transcription acid inhibitors can cause pancreas inflammation and nervous system to destroy.Also have various complication and other serious drug reaction even cause death.Protease suppresses side effect and comprises nauseating, diarrhoea and other gastrointestinal symptoms, can also react with other medicines, has side effects." " so far, HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) can be killed all without any a kind of AIDS virus resisting medicine, if want to eradicate HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), must raise immunity.The comprehensive immunologic function of rebuilding the patient reaches replys at the specific immune of waiting for an opportunity to infect with HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), can kill the residual virus of hiding." " HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) is attacked human body CD4+T cell, and how activating the immunocyte that has been damaged also is a very arduous challenge.”
The purpose of this utility model be to provide and the method for Applied Physics immunity (immunity) overcome the weak point of chemo-immunity in the prior art (medicine immunity) treatment acquired immune deficiency syndrome (AIDS) and provide a kind of relatively simple for structure, cost is lower, can effectively improve human immune system's function, activation is subjected to the immunocyte of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) damage, rebuild patient's comprehensive immunologic function, raising waits for an opportunity to infect specific immune responsibility with HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) to HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), can effectively suppress to kill and wound the apparatus for treating Aids of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), no obvious adverse reaction.For human treatment's acquired immune deficiency syndrome (AIDS) provides a kind of new design and armarium.
Theoretical foundation of the present utility model is: the interior environment of forming the most basic small tissue (cell, nucleus, cell membrane, Cell sap, albumen, enzyme, nucleic acid, gene, the base equity) existence of life entity can be considered field, organic little territory, gene are field, organic little territory chain, and the field of external environment condition is the field, foreign lands.Under certain field, foreign lands and the organic little territory field interactions, reach the biobalance attitude between the two, cell then can normally be survived, and gene then can normally duplicate, and albumen, enzyme are normally synthetic and bring into play its function.If be in nonequilibrium state, will be suppressed even death.The field, organic little territory in the responsive site of gene is subjected to regulation and control excitation, the enhancing of field, foreign lands, and gene replication speed may be accelerated, and the vigor of cell, albumen, enzyme increases, and then can be suppressed on the contrary even can't duplicate, and bioprotein, enzyme are subjected to the regulation and control of field, foreign lands.To the natural magnetic field of the overall process of life, gravity (gravitation) harmony (vibration) is unusual key factor.Utilize HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) and normal cell to apply the heavy sound field of low frequency magnetic selectively, impel the strand of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) gene and double-strand break to rise, quicken the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) degeneration necrosis what the difference of permeability, conductivity, dielectric constant caused.Simultaneously, utilize the heavy sound of magnetic to wait physical field to improve the replication rate of immunocyte gene, promote gene synthetic, enhance immunity specific reaction and replying improves function of immune system as a result, and this method is called physics immunity (immune).According to this theory, therefore, can effectively improve function of immune system, activate the immunocyte that is subjected to the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) damage, the comprehensive immunologic function of rebuilding the patient by the heavy sound field of the synthetic magnetic of special control law, raising strengthens the ability that AIDS virus resisting waits for an opportunity to infect to the specific immune responsibility of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus).Simultaneously, suppress reverse transcriptase effectively.Because the heavy sound wave of magnetic adopts frequency agility and pre-programmed signal modulation (now ripe) technology, the heavy sound wave energy of magnetic is selected among multiple signal pattern, multiple frequency, multiple assembled state on demand, fast and effeciently to suppress to kill and wound, quicken its degeneration necrosis far above the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) speed of mutation.
This utility model is made up of the heavy sound source of main body, magnetic of tunnel type, mobile therapeutic bed, control station.(1) is provided with installing rack in the upper and lower, left and right of tunnel type main body, each installing rack can be arranged the heavy sound source of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil and 2-38 binding post, magnetic excitation coil is provided with magnetic shield outward, installing rack is provided with 2-26 acoustic generator, and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab that has scanning holes; (2) the heavy sound source of the magnetic on the installing rack is installed in shielding-harmonic shock cover by annular damping noise reduction pad, the bottom of shielding-harmonic shock cover and have the noise abatement hole louvre of holding concurrently all around; Be with a rolling disc in the rotating shaft of the heavy sound source of magnetic by buncher, shrinkage pool is arranged on the rolling disc, be embedded with kicker magnet in the shrinkage pool, all be embedded with magnetic shield between rolling disc and the kicker magnet, have pressing plate or pressure ring to compress kicker magnet; On rolling disc, also be provided with magnetic excitation coil and binding post; The top of motor is provided with fixing head, and its surface is parallel with rolling disc, has the hole on the fixing head, is connected and fixed the sound source head; (3) removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along guide rail by a pendulum position system, is made up of slide rail, driving device and localizer; (4) control station is controlled magnetic field impulse frequency, burst of pulses and the integrated intensity of the heavy sound source of magnetic with electronic circuit or computer, to monitoring, form simultaneously by control template, control panel, special switch and computer, interface board, special-purpose software by the duty of pendulum position system; (5) the computer control circuit is the power supply of computer, variable-frequency governor by regulated power supply, and computer provides control signal to variable-frequency governor and makes the heavy sound source work of magnetic, and available common, fuzzy or chaos controlling program realizes common, fuzzy or chaos controlling.
This utility model compared with prior art has following advantage:
1. this utility model can increase immune function of human body effectively through evidence, activates the immunocyte of damaged, improves the specific immune responsibility, strengthens anti-ability of waiting for an opportunity to infect.This utility model shows through zoopery and long-term clinical observation: the interleukin-2-receptor (IL-2R, IL-12R) of interleukin (IL-2, IL-12) is increased; Make CD4
+T, CD8
+T and CD3
+T increases; Folliculus shape dendritic cell (FDCs) are increased; Interferon-' alpha ', interferon-are increased, help rebuilding patient's comprehensive immunologic function.
Rat soluble interleukin-6-2 receptor result of variations
Different time (my god) and interleukin-2 R (IU/ml) group
7 14 30 60 90 test group 143.00 ± 20.00
*156.00 ± 14.00
*169.00 ± 33.00
Δ150.00 ± 32.00
*201.00 ± 41.00
ΔMatched group 126.00 ± 14.00 129.00 ± 0.00 135.00 ± 12.00 136.00 ± 0.00 132.00 ± 8.00*P＜0.05 Δ P＜0.01
Rat treatment different time CH
50Measurement result
The treatment different time (my god) and and CH
50(IU/ml) group
7 14 30 60 90 test group 91.50 ± 46.60
*81.50 ± 52.00 133.00 ± 0.00 149.75 ± 29.00
Δ166.50 ± 33.50
*Matched group 83.30 ± 16.70 78 ± 38.20 133.00 ± 0.00 99.80 ± 33.20 155.30 ± 43.30*P＜0.05 Δ P＜0.01
Rat treatment different time determination of immunoglobulin result
Different time (my god) and immunoglobulin (IU/ml) project group
7 14 30 60 90
Test group 96.20 ± 10.40
*129.90 ± 35.70
*129.40 ± 40.60 119.10 ± 20.00
Δ129.90 ± 38.80IgG matched group 87.80 ± 21.00 98.80 ± 20.20 133.30 ± 67.10 95.60 ± 10.90 116.40 ± 32.60
Test group 170.70 ± 36.40
Δ257.80 ± 10.50
Δ239.30 ± 47.10
Δ174.10 ± 26.20 127.60 ± 15.20
*IgA
Matched group 126.50 ± 32.20 207.90 ± 35.20 197.30 ± 37.80 160.20 ± 15.20 106.00 ± 21.60*P＜0.05 Δ P＜0.01
2. gastro-intestinal digestion system, hemopoietic system and nervous system there are the coordinated regulation therapeutical effect, and tangible curative effect is arranged;
3. this utility model has inhibitory action with enough high strength and long treatment to reverse transcriptase and virus protein, enzyme, makes the RNA reverse transcription of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) be difficult to carry out, thereby quickens the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) degeneration necrosis.Useful albumen, enzyme there are activation potentiation, bring into play the peculiar two-way choice adjusting function of the heavy ping of many gradients magnetic;
4. after the doses treatment, patient's appetite increases, full of vitality, body weight gain, and life quality obviously improves;
Mice body weight change result
Treatment time (my god) and body weight (g)
Group
0 10 20
Test group 21.91 ± 1.08 28.66 ± 1.66 33.04 ± 0.54
*
Matched group 22.18 ± 0.61 27.05 ± 1.52 28.88 ± 2.91
*P＜0.05
5. this therapy apparatus is safe and reliable, does not find the side effect that shows.Through long-term clinical observation proof hemogram index, biochemical indicator, hormonal system, nervous system, audition, vision and the heart, liver,spleen,kidney, lung, gastrointestinal, pancreas, urinary system etc. are had no adverse effects, and the function of improvement is arranged;
Mouse test group routine blood test index
Treatment time (my god) and routine blood test index project
10 20WBC (* 10
9Individual/L) 11.26 ± 1.75 11.35 ± 6.16N (%), 23.49 ± 9.66 32.41 ± 3.08L (%), 76.24 ± 7.41 67.45 ± 2.91PLT (* 10
9/ L) 200.3 ± 23.10
Δ221.3 ± 7.79
ΔHb (g/L) 139.88 ± 0.83 142.37 ± 7.92
*Δ P＜0.01 * P＜0.05
Mice matched group routine blood test change indicator
Treatment time (my god) and routine blood test index project
10 20WBC (* 10
9Individual/L) 10.72 ± 9.18 10.99 ± 16.42N (%), 20.34 ± 12.22 30.05 ± 9.22L (%), 76.88 ± 12.00 67.95 ± 7.78PLT (* 10
9/ L) 172.30 ± 25.40 190.30 ± 29.60Hb (g/L), 127.53 ± 24.78 132.99 ± 0.33 Δ P＜0.01 * P＜0.05
The result of variations group cardiopulmonary spleen Liver and kidney body weight test group 0.5 ± 0.06 0.22 ± 0.08 of mouse test organ coefficient
*2.64 ± 0.97
*0.54 ± 0.09 33.04 ± 0.54 organ coefficient (%) 1.15 0.66 1.99 1.63 matched groups 0.47 ± 0.08 0.16 ± 0.07 1.75 ± 0.36 0.51 ± 0.11 29.88 ± 2.91 organ coefficient (%), 1.57 0.54 5.85 1.71*P＜0.05
Rat test group routine blood test result of variations
Treatment time and routine blood test index project
7 14 30 60 90WBC (* 10
9Individual/L) 22.00 ± 2.75 21.65 ± 1.1.27 19.35 ± 2.35 19.35 ± 3.98 18.43 ± 2.09N, (%) 9.30 ± 6.70 9.25 ± 2.60 9.25 ± 3.70 11.75 ± 13.80 12.30 ± 5.10L, (%) 90.75 ± 2.60 90.75 ± 3.40 90.75 ± 3.14 86.00 ± 16.20 87.70 ± 5.10M, (%) 000 2.00 ± 2.80 0A, (%) 0000 0Hb, (g/L) 126.70 ± 7.60 129.00 ± 12.10 136.50 ± 11.40*132.50 ± 8.10
Δ139.60 ± 14.70
Δ* P＜0.05 Δ P＜0.01
Rat test matched group routine blood test result of variations
Treatment time and routine blood test index project
7 14 30 60 90WBC (* 10
9Individual/L) 19.70 ± 1.56 17.60 ± 5.70 17.3 ± 5.20 18.70 ± 9.90 16.76 ± 2.53N, (%) 9.50 ± 1.40 9.25 ± 4.90 10.00 ± 1.40 10.50 ± 0.70 10.00 ± 2.70L, (%) 90.50 ± 0.70 90.50 ± 4.90 90.75 ± 1.40 89.50 ± 0.70 90.00 ± 2.70M, (%) 0000 0A, (%) 0.50 ± 0.70 000 0Hb, (g/L) 128.00 ± 3.00 126.00 ± 5.70 126.00 ± 0.00 118.00 ± 0.00 114.70 ± 7.20
Rat test group blood results of biochemical
Treatment time (my god) and the biochemical indicator project
7 14 30 60 90TP(g/L) 78.20±5.10 89.60±11.30 86.00±12.10 78.80±3.30 88.50±11.80ALB(g/L) 44.40±2.50 44.60±4.90 45.30±10.40 40.40±1.70 42.20±4.30GLU(mmol/L) 7.04±1.00 5.07±1.54 5.17±1.54 5.72±0.23 5.38±1.42CHDL(mmmol/L)?2.13±0.15 2.81±0.33 2.13±1.20 2.31±0.05 2.13±0.26ALP(IU/ml) 468.3±137.00 495.00±148.00 514.00±119.00 470.00±121.00?488.00±182.00
Rat matched group blood results of biochemical
Treatment time (my god) and the biochemical indicator project
7 14 30 60 90TP(g/L) 78.20±2.90 75.60±10.10 84.60±0.30 75.70±8.30 84.70±3.90ALB(g/L) 43.90±3.70 48.50±3.80 44.30±3.30 46.30±5.70 42.40±3.34GLU(mmol/L) 7.70±0.10 5.60±0.28 5.55±0.71 5.23±0.78 5.60±0.84CHDL(mmmol/L)?2.80±0.11 2.20±0.68 2.13±0.30 2.32±0.70 1.96±0.52ALP(IU/ml) 453.00±190.00 389.00±127.00?422.00±7.80?470.00±247.00 432.00±89.00
6. this utility model has the effect that promotes variation to lymph surface chemotactic factor CCR2 and CCR5, to postponing the acquired immune deficiency syndrome (AIDS) morbidity and being difficult for aids infection virus, produces antibody of AIDS virus to promoting human body, and is very favourable.
Rat periphery blood lymphocyte conversioning test result
Treatment time (my god) and cell transformation rate (%) project
7 14 30 60 90 test group 0.53 ± 0.00
*0.60 ± 0.02
*0.53 ± 0.09
*0.56 ± 0.06 0.59 ± 0.00
*Matched group 0.40 ± 0.00 0.43 ± 0.07 0.41 ± 0.07 0.49 ± 0.04 0.41 ± 0.03
*P＜0.05
7. this therapy apparatus advanced design, harmless to patient and medical personnel and Environmental security, and cost is low, maintainable good, reliability height, life-span are long, easy to use.
Below be the drawing explanation of this utility model Figure of description:
Fig. 1 is that system of the present utility model constitutes schematic front view.
Fig. 2 is that system of the present utility model constitutes the signal left view.
Fig. 3 is the cutaway view of the heavy sound source of the common or superconducting coil magnetic of this utility model.
Fig. 4 is the vertical view of the heavy sound source of the common or superconducting coil magnetic of this utility model.
Fig. 5 is the cutaway view of the heavy sound source of this utility model magnetic.
Fig. 6 is the vertical view of the heavy sound source of this utility model magnetic.
Fig. 7 is the theory diagram of the electronic control circuit of the heavy sound source of this utility model magnetic.
Fig. 8 is the program control type line principle block diagram that prelists of the heavy sound source of this utility model magnetic.
Fig. 9 is the electronic computer control sequence schematic diagram of the heavy sound source of this utility model magnetic.
This utility model is described in further detail below with reference to embodiment and accompanying drawing:
Embodiment 1. is referring to Figure of description 1-9, a kind of apparatus for treating Aids is by the main body of tunnel type (1) (tunnel type treatment space is a rectangle in the present embodiment), the heavy sound source (2) of magnetic, therapeutic bed (3), control station (4) is formed: (1) is on the tunnel type main body, down, a left side, the right side is provided with installing rack (5), each installing rack can be arranged the heavy sound source (2) of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil (6) and 2-38 binding post (7), this magnetic excitation coil is common or superconduction 8 fonts, coil and sense of current can be left-handed can be dextrorotation also, coil axis is adjustable.Magnetic excitation coil is provided with magnetic shield (8) outward, and installing rack is provided with 2-26 acoustic generator (9), and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab that has scanning holes (10) (11).(2) the heavy sound source of the magnetic on the installing rack (2) is installed in shielding-harmonic shock cover (13) by annular damping noise reduction pad (12).The annular cushion is to be composited by special purpose spring corrugated steel and high elastic rubber, sponge.The bottom of shielding-harmonic shock cover and have the noise abatement hole louvre (14) of holding concurrently all around, the noise abatement hole can decay to 5-20dB with unwanted audio frequency; Be with a rolling disc (16) in the rotating shaft of the heavy sound source of magnetic by buncher (15), rolling disc is made by reinforced plastics, carbon fibre composite or metal material.3-180 shrinkage pool (17) arranged on the rolling disc, be linearity or nonlinear Distribution, symmetry or asymmetric geometry.Be embedded with kicker magnet (18) in the shrinkage pool, be rare-earth permanent magnet or ferrum oxygen permanent magnet, magnetic induction is 0.1mT-12T/S.All be embedded with magnetic shield (19) between rolling disc and the kicker magnet, have pressing plate or pressure ring (20) to compress kicker magnet; The top of motor is provided with fixing head (21), and plate face edge is than thick middle, and its surface is parallel with rolling disc, and keeps at a distance, and has 2-160 hole (22) on the fixing head, is connected and fixed sound source (23).(3) removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along slide rail (24) by a pendulum position system, is made up of slide rail (25), driving device (26) and localizer (27).This tunnel type treatment space can be cylindrical, rectangle or polygon (as Fig. 1 is rectangle, and Fig. 5 is a polygon).(4) control station (4) is controlled magnetic field impulse frequency, burst of pulses and the integrated intensity of the heavy sound source of magnetic with electronic circuit or computer, to monitoring, form simultaneously by control template, control panel, special switch and computer, interface board, special-purpose software by the duty of pendulum position system; The control table top has display (28), PC main frame (29), operation keyboard (30), character display (31), Artificial Control panel (32), host computer control cable (33) and therapeutic bed control cable (34); (5) the computer control circuit is the power supply of computer, buncher by regulated power supply, and computer provides control signal to variable-frequency governor and makes the heavy sound source work of magnetic, and available common, fuzzy or chaos controlling program realizes common, fuzzy or chaos controlling.
The rotating speed of the heavy sound source buncher of designed magnetic is 0-10000 rev/min, and the frequency of magnetic field impulse is that the heavy ping number of 0-8MHz, magnetic is 0-6.8 * 10
9Individual/second, sound frequency rate is 0-48MHz, and sound field comprises infrasonic sound, low, middle and high frequency rate, ultrasonic, its equivalent sound level≤70dB (A), and acoustical power is 1-100mW/cm
2
Software work principle of the present utility model is as follows: initialize routine is carried out in the start back, on display, show the start original state subsequently, wait for the heavy sound source operating frequency setting of keyboard input magnetic, select two dimension or three-dimensional control sequence with keyboard or mouse then, select control cycle again, as 10 minutes or 15 minutes, the process procedures name has been made the control key of icon and band literal at desktop system, use the click control key, process control is carried out automatically, until end.
The designed apparatus for treating Aids of this utility model can be applied to treat acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient.The method of using is: the patient that will suffer from the patient of acquired immune deficiency syndrome (AIDS) or carry HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) sends on the removable therapeutic bed, gauge tap on the start-up control platform, patient is sent into tunnel type treatment space, start the heavy sound source of magnetic, patient is in the heavy sound field of magnetic, patient was treated 10-30 minute, and every day 1-2 time, look patient's state of an illness and order each course of treatment.
The designed apparatus for treating Aids of this utility model can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
Embodiment 3. is referring to Figure of description 1-5, a kind of apparatus for treating Aids, its structure is similar substantially to embodiment 1, is to have arranged the heavy sound source (2) of 4 magnetic, 20 magnetic excitation coils (6), 20 binding posts (7) and 12 acoustic generators (9) on the installing rack of designed tunnel type main body.The noise abatement hole (14) of shielding-harmonic shock cover can decay to 5dB with unwanted audio frequency.80 shrinkage pools (17) are arranged on the rolling disc, be linear, be symmetrically distributed and arrange.Ferrum oxygen permanent magnet, magnetic induction are 8T/S.Have 60 holes (22) on the fixing head, be connected and fixed sound source (23).The rotating speed of the heavy sound source buncher of designed magnetic is 1000 rev/mins, and the frequency of magnetic field impulse is that the heavy ping number of 4MHz, magnetic is 4 * 10
9Individual/second, sound frequency rate is 20MHz, and sound field comprises infrasonic sound, low, middle and high frequency rate, ultrasonic, its equivalent sound level≤70dB (A), and acoustical power is 50mW/cm
2The software work principle is with embodiment 1.
The designed apparatus for treating Aids of this utility model can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
The designed apparatus for treating Aids of this utility model can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
The designed apparatus for treating Aids of this utility model can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
Claims (7)
1. apparatus for treating Aids: it is characterized in that: the heavy sound source (2) of main body (1), magnetic, therapeutic bed (3), control station (4) by tunnel type are formed:
1.1 be provided with installing rack (5) in the upper and lower, left and right of tunnel type main body, each installing rack can be arranged the heavy sound source (2) of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil (6) and 2-38 binding post (7), magnetic excitation coil is provided with magnetic shield (8) outward, installing rack is provided with 2-26 acoustic generator (9), and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab that has scanning holes (10) (11);
1.2 the heavy sound source of the magnetic on the installing rack (2) is installed in shielding-harmonic shock cover (13) by annular damping noise reduction pad (12), the bottom of shielding-harmonic shock cover and have the noise abatement hole louvre (14) of holding concurrently all around; Be with a rolling disc (16) in the rotating shaft of the heavy sound source of magnetic by buncher (15), 3-180 shrinkage pool (17) arranged on the rolling disc, be embedded with kicker magnet (18) in the shrinkage pool, all be embedded with magnetic shield (19) between rolling disc and the kicker magnet, have pressing plate or pressure ring (20) to compress kicker magnet; The top of motor is provided with fixing head (21), and plate face edge is than thick middle, and its surface is parallel with rolling disc, and keeps at a distance, and has 2-160 hole (22) on the fixing head, is connected and fixed sound source (23);
1.3 removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along slide rail (24) by a pendulum position system, is made up of slide rail (25), driving device (26) and localizer (27);
1.4 control station (4) is controlled magnetic field impulse frequency, burst of pulses and the integrated intensity of the heavy sound source of magnetic with electronic circuit or computer, to being monitored by the duty of pendulum position system, hardware components is made up of control template, control panel, special switch and computer, interface board, special-purpose software simultaneously; The control table top has display (28), PC main frame (29), operation keyboard (30), character display (31), Artificial Control panel (32), host computer control cable (33) and therapeutic bed control cable (34);
1.5 the computer control circuit is the power supply of computer, buncher by regulated power supply, computer provides control signal to variable-frequency governor and makes the heavy sound source work of magnetic, and available common, fuzzy or chaos controlling program realizes common, fuzzy or chaos controlling.
1.6 the software work principle is as follows: initialize routine is carried out in the start back, on display, show the start original state subsequently, wait for the heavy sound source operating frequency setting of keyboard input magnetic, select two dimension or three-dimensional control sequence with keyboard or mouse then, select control cycle again, as 10 minutes or 15 minutes, the process procedures name has been made the control key of icon and band literal at desktop system, use the click control key, process control is carried out automatically, until end.
2. apparatus for treating Aids according to claim 1 is characterized in that, the shrinkage pool of the 3-180 in 1.2 on the said rolling disc is linearity or nonlinear Distribution, symmetry or asymmetric geometry.
3. apparatus for treating Aids according to claim 1 is characterized in that, the kicker magnet that said rolling disc embeds in 1.2 is rare-earth permanent magnet or ferrum oxygen permanent magnet, and magnetic induction is 0.1mT-12T/S.
4. apparatus for treating Aids according to claim 1 is characterized in that, the rotating speed of the heavy sound source buncher of said magnetic is 6-10000 rev/min in 1.2 and 1.4, and the frequency of magnetic field impulse is that the heavy ping number of 0-8MHz, magnetic is 0-6.8 * 10
9Individual/second, sound frequency rate is 0-48MHz, and sound field comprises infrasonic sound, low, middle and high frequency rate, ultrasonic, its equivalent sound level≤70dB (A), and acoustical power is 1-100mW/cm
2
5. apparatus for treating Aids according to claim 1 is characterized in that, the magnetic excitation coil in 1.2 on the said tunnel type main body is common or superconduction 8 fonts, coil and sense of current can be left-handed can be dextrorotation also, coil axis is adjustable.
6. apparatus for treating Aids according to claim 1 is characterized in that, the noise abatement hole of said shielding-harmonic shock cover can decay to 5-20dB with unwanted audio frequency in 1.2;
7. apparatus for treating Aids according to claim 1 is characterized in that, said tunnel type treatment space can be cylindrical, rectangle or polygon in 1.3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02222777 CN2553828Y (en) | 2002-05-31 | 2002-05-31 | AIDS treatment apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02222777 CN2553828Y (en) | 2002-05-31 | 2002-05-31 | AIDS treatment apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN2553828Y true CN2553828Y (en) | 2003-06-04 |
Family
ID=33700612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02222777 Expired - Fee Related CN2553828Y (en) | 2002-05-31 | 2002-05-31 | AIDS treatment apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN2553828Y (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301762C (en) * | 2002-05-31 | 2007-02-28 | 王德全 | Apparatus for treating Aids |
-
2002
- 2002-05-31 CN CN 02222777 patent/CN2553828Y/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301762C (en) * | 2002-05-31 | 2007-02-28 | 王德全 | Apparatus for treating Aids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1032676C (en) | Low frequency rotation permanent magnetic field therapeutic device | |
| CN1206975C (en) | Method for integrating sound, light electric, magnetic, heat, medicinal and mechanical treatment method into one, inducing and removing obstruction in channels and its product | |
| CN101068594A (en) | An ultrasonic equipment for treatment of osteoarthritis | |
| CN1909944A (en) | Electromagnetic apparatus for the treatment of lesions associated with inadequate blood perfusion | |
| CN1032420A (en) | Utilize magnetic force treatment human body not accommodate the device of disease | |
| CN107185107A (en) | A kind of ultrasonic direct current current iontophoresis system | |
| CN2553828Y (en) | AIDS treatment apparatus | |
| CN1301762C (en) | Apparatus for treating Aids | |
| CN201316486Y (en) | Ultrasonic dual-frequency whole body sono-dynamic therapy system | |
| Goldshmit et al. | Treatment with pulsed extremely low frequency electromagnetic field (PELF-EMF) exhibit anti-inflammatory and neuroprotective effect in compression spinal cord injury model | |
| CN104829707B (en) | The leptin activity peptide and its encoding gene and application of one CD ring and E spiral region mutations | |
| CN103710308B (en) | Muramyl dipeptide is utilized to induce the method for DC-CIK | |
| CN1861191A (en) | Application of human sDR5 protein as medicine to treat virus hepatitis B | |
| CN1282491C (en) | Therapeutic device for curing diabetes and cardiovascular disease | |
| JP2007509063A5 (en) | ||
| CN110898333A (en) | Health management instrument for assisting in repairing anxiety and depression and use method | |
| CN103357119A (en) | Laser magnetic therapy instrument | |
| UA87110U (en) | Method for treating chronic viral hepatitis c | |
| CN203074767U (en) | Cardiovascular treatment machine | |
| CN104829705B (en) | The leptin activity peptide of one C spiral region mutation and its encoding gene and application | |
| CN215779883U (en) | Cardiovascular internal medicine physiotherapy device | |
| CN100374170C (en) | Blood treatment device for treating microcirculatory disturbance | |
| CN221673230U (en) | Radiation protection device for epithermal neutron beam | |
| US20220152195A1 (en) | Methods of preventing and treating viral infections | |
| CN202173564U (en) | Lower limb training bed for neurology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |